Skip to content

Psilocybin and psychedelic-assisted therapy: all studies

Page 9 of 26: studies 81 to 90 of 252, newest first. Back to the psilocybin and psychedelic-assisted therapy overview

Research

Recommendations and Consensus Statements on Psilocybin-Assisted Psychotherapy (PAP) for Depression: A Rapid Review and Thematic Analysis

Open Science Framework 2025 Aimee Freeburn, Alene Sze Jing Yong, Simon Bell preprint

This rapid review aims to synthesise recommendations and statements from international clinical guidelines, consensus statements, and position statements regarding the medical use of psilocybin-assisted psychotherapy (PAP) in adults living with depression.

DOI: 10.17605/osf.io/gzvb3 (opens in new tab) Thematic analysis Psychotherapist Medline Position paper

The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.

Therapeutic Advances in Psychopharmacology 2025 Diana McHerron, Michaela Barber, Rachel Ham et al.

Physical touch is often included as a supportive or therapeutic tool in psychedelic-assisted therapy (PAT), involving instrumental forms of physical contact, supportive touch and somatic techniques. However, participants under the influence of psychedelics have reduced capacity to provide consent, are more suggestible and may experience and interpret therapeutic touch in ways they did not...

"Facing Death. . . Now, That's a Serious Thing to Confront" A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms.

Integrative Cancer Therapies 2025 Haley D M Schuman, Sofia Barkova, Raèf Mina et al. 2 citations

People living with cancer (PLWC) often face profound existential distress that is insufficiently addressed by conventional psychosocial supports. This qualitative study explored PLWC's attitudes, beliefs, and experiences regarding psychedelic-assisted therapy (PAT) as a novel approach to addressing psychosocial suffering, particularly existential distress. Fifteen participants with varying...

Post-traumatic stress disorder in psychedelic research.

International review of neurobiology 2025 Tijmen Bostoen, Stephan Tap, Joost J. Breeksema et al. 1 citation

Post-Traumatic Stress Disorder (PTSD) is a severe psychiatric condition that develops after exposure to trauma such as combat, natural disasters, or assault. It is characterized by re-experiencing trauma, avoidance, hyperarousal, and negative alterations in cognition and mood. Since its formal inclusion in the Diagnostic and Statistical Manual of Mental Disorders (DSM)-III in 1980, PTSD has...

Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.

International review of neurobiology 2025 Stephan Tap, Tijmen Bostoen, Joost J. Breeksema et al. 4 citations

Patients with a life-threatening disease (LTD) sometimes suffer from end-of-life distress (EOLD) which refers to the physical, psychological, emotional, and spiritual suffering related to chronic illness and the possibility of death. Palliative care interventions seek to improve the quality of life of patients with EOLD and their significant others. Currently, a range of psychological and...

Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial

medRxiv 2025 Benjamin R. Lewis, John Hendrick, Kevin Byrne et al. 3 citations preprint

Abstract Objective This clinical trial sought to evaluate the safety and preliminary efficacy of psilocybin and MBSR for frontline healthcare providers with symptoms of depression and burnout related to the COVID-19 pandemic. Methods This was a randomized controlled trial that enrolled physicians and nurses with frontline clinical work during the COVID-19 pandemic and symptoms of depression and...

Music as a collaborating actor: new insights into the nature and role of music in psychedelic-assisted psychotherapy.

Frontiers in Psychiatry 2025 Justin Dwyer, Robert B. Johnston, Clare O'Callaghan et al. 5 citations

Music has been identified as a central feature of psychedelic-assisted psychotherapy (PAP) and has hitherto been understood to amplify the psychedelic experience in a predictable way that has been codified into music recommendations and playlists. To re-evaluate the nature and role of music within the participant's world during psychedelic-assisted psychotherapy. Phenomenological analysis of...

Informed Consent in Psychedelic-Assisted Therapy.

Current Topics in Behavioral Neurosciences December 31, 2024 Mazdak M. Bradberry, Paul S. Appelbaum, Natalie Gukasyan 7 citations

Humans have long used classical serotonergic psychedelics, such as psilocybin, for a variety of purposes. Entactogens, such as methylenedioxymethamphetamine (MDMA), emerged during the twentieth century and have likewise seen use in a broad range of settings. Interest has arisen in the use of classical psychedelics and entactogens, together termed "psychedelics," for therapeutic purposes in...

Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design

Journal of Eating Disorders December 27, 2024 Elena Koning, Cristiano Chaves, Elisa Brietzke et al. 2 citations

Eating disorders (EDs) are a group of debilitating mental illnesses characterized by maladaptive eating behaviors and severe cognitive-emotional dysfunction, directly affecting 1-3% of the population. Standard treatments are not effective in approximately one third of ED cases, representing the need for scientific advancement. There is emerging evidence for the safety and efficacy of...

The safety of psilocybin-assisted psychotherapy: A systematic review

Australian & New Zealand Journal of Psychiatry December 13, 2024 Rosana Freitas, Efstathia Stephanie Gotsis, Alexander T. Gallo et al. 14 citations

Introduction: Psilocybin, a classical psychedelic, has been rescheduled for use in psilocybin-assisted psychotherapy for treatment-resistant depression in Australia. While evidence for its use is promising, understanding the associated risks is crucial. Accordingly, this review aims to collate adverse event data from psilocybin-assisted psychotherapy clinical trials and evaluate its definition,...

DOI: 10.1177/00048674241289024 (opens in new tab) Psilocybin Adverse effect Suicidal ideation Clinical trial +4